INTRODUCTION {#h0.0}
============

Clinical and epidemiological studies have demonstrated an association of malnutrition, dietary deficiency, and infection ([@B1], [@B2]). Infections are more frequent and can be more chronic in primary malnourished individuals ([@B2], [@B3]), with evidence suggesting that infection further weakens the host by reducing nutrient uptake and impeding the ability to mount an effective immune response ([@B4][@B5][@B6]). However, relatively little is known about the physiological and immunological signatures linking general malnutrition or specific dietary deficiencies to infection susceptibility.

Vitamin B~12~ (cobalamin \[Cbl\]) serves as an essential cofactor in the cellular growth of most prokaryotic organisms. While bacterial species such as *Escherichia coli* and *Salmonella enterica* have the ability to produce Cbl *de novo* anaerobically, mammals obtain Cbl exclusively from animal protein dietary sources ([@B7]). Mammalian Cbl absorption is a highly specific process, with the secreted protein gastric intrinsic factor (Gif) being responsible for transporting Cbl through the small intestine and facilitating endocytosis in the distal ileum ([@B8]). In humans, Cbl deficiency is linked to a variety of clinical conditions, including megaloblastic anemia, optic atrophy, degeneration of the spinal cord, renal abnormalities, and malabsorption ([@B8][@B9][@B11]). The impact of Cbl deficiency is likely multifactorial, as it normally plays a role in cellular metabolism with DNA stress, cellular oxidative damage, alterations in odd-chain fatty acid and cholesterol synthesis, and anaplerosis as consequences ([@B8], [@B12][@B13][@B15]).

We have recently shown that mice lacking Gif exhibit significant growth retardation and low bone mass, with the penetrance of this phenotype showing maternal influences ([@B16]). Here we characterize the susceptibility of this mouse line to different infection challenges, highlighting maternal and metabolic influences on serum Cbl levels and susceptibility.

RESULTS {#h1}
=======

Gif-deficient mice were identified as part of a high-throughput screen as susceptible to a bacterial challenge. {#s1.1}
---------------------------------------------------------------------------------------------------------------

By high-throughput screening, we challenge small groups of novel reporter-tagged knockout mouse lines with different pathogens ([@B17]) (<http://www.mousephenotype.org>). One of the lines we screened harbored a defined mutation in the gene encoding Gif, a glycoprotein regulating the highly specific intestinal endocytosis of Cbl. *Gif*^tm1a/tm1a^ mice exhibit altered susceptibility to both *S. enterica* serovar Typhimurium and *Citrobacter rodentium* challenges (<http://www.mousephenotype.org/data/genes/MGI:1202394>). These *Gif* mutant mice were generated on a C57BL/6N background by using a knockout first promoter-driven allele targeting *Gif* intron 5 on chromosome 19 (see [Text S1](#textS1){ref-type="supplementary-material"} in the supplemental material for further details). Transcriptional and immunohistological analyses showed that *Gif* expression was abolished in *Gif*^tm1a/tm1a^ mice and restricted to the stomachs of wild-type mice ([@B16]) ([Fig. 1a](#fig1){ref-type="fig"} shows the immunohistochemical analysis results obtained).

![*Gif*^tm1a/tm1a^ mice exhibit signatures of Cbl deficiency. (a) Immunofluorescence analysis of the glandular stomach regions of wild-type (i) and *Gif*^tm1a/tm1a^ (ii) mice stained (red) for the presence of Gif with specific antiserum (×400 magnification). (b) Representative photograph of 8-week-old *Gif*^tm1a/tm1a^ and wild-type pups from *Gif*^tm1a/tm1a^ (left), *Gif*^tm1a/+^(middle), or wild-type (right) dams. (c) Mean body weights of F~1~ *Gif*^tm1a/tm1a^ (red triangles), F~2~ *Gif*^tm1a/tm1a^ (purple triangles), and wild-type (blue circles) mice between 3 and 16 weeks of age. (d) Blood plasma Cbl concentrations *Gif*^tm1a/tm1a^ and wild-type mice. Dashed lines show the detection limits of the analyzer. Black bars represent geometric mean values. \*\*\*, *P* \< 0.001; \*\*, *P* \< 0.01; \*, *P* \< 0.05 (ANOVA with Dunn's multiple-comparison *post hoc* test).](mbo0031628630001){#fig1}

Subsequent breeding identified two phenotypically distinct types of *Gif*^tm1a/tm1a^ mice. F~1~ *Gif*^tm1a/tm1a^ mice resulting from *Gif*^tm1a/+^ × *Gif*^tm1a/+^ matings ([Fig. 1b](#fig1){ref-type="fig"}) were indistinguishable from heterozygous *Gif*^tm1a/+^ mice or their wild-type counterparts with respect to multiple characteristics, including their susceptibility to either an *S*. Typhimurium or a *C. rodentium* challenge (data not shown). In contrast, F~2~ *Gif*^tm1a/tm1a^ mice that resulted from *Gif*^tm1a/tm1a^ × *Gif*^tm1a/tm1a^ matings exhibited stunted growth ([Fig. 1b](#fig1){ref-type="fig"} and [c](#fig1){ref-type="fig"}) and enhanced susceptibility to both *S*. Typhimurium and *C. rodentium* challenges. We therefore examined these phenotypic characteristics further.

F~2~ *Gif*^tm1a/tm1a^ mice are deficient in Cbl and have alterations in red blood cell and plasma chemistry. {#s1.2}
------------------------------------------------------------------------------------------------------------

To ascertain if *Gif*^tm1a/tm1a^ mice were Cbl deficient, we measured the blood plasma Cbl concentrations of wild-type and *Gif*^tm1a/tm1a^ mice ([Fig. 1d](#fig1){ref-type="fig"}). We found that all of the wild-type mice exhibited high plasma Cbl concentrations (≥2,000 ng/liter), with F~1~ *Gif*^tm1a/tm1a^ mice showing various levels of blood plasma Cbl deficiency. However, blood plasma from F~2~ *Gif*^tm1a/tm1a^ mice consistently exhibited at least 20-fold lower Cbl levels than that from their wild-type counterparts ([Fig. 1d](#fig1){ref-type="fig"}). Further blood analysis showed that naive F~2~ *Gif*^tm1a/tm1a^ mice exhibited phenotypes similar to those of humans with severe Cbl deficiency ([@B9], [@B11]), with these F~2~ mice having consistently lower erythrocyte counts (see [Fig. S1b](#figS1){ref-type="supplementary-material"}, part i, in the supplemental material) and a greater mean corpuscular volume (MCV; see [Fig. S1b](#figS1){ref-type="supplementary-material"}, part ii) than equivalent F~1~ *Gif*^tm1a/tm1a^ and wild-type mice. Moreover, megakaryocytes found in the spleens of F~2~ *Gif*^tm1a/tm1a^ mice were often hyperlobulated with hypersegmented nuclei indicative of cell cycle irregularities compared to wild-type cells (see [Fig. S1a](#figS1){ref-type="supplementary-material"}) ([@B11]).

Furthermore, in comparison to blood plasma collected from equivalent F~1~ *Gif*^tm1a/tm1a^ and wild-type mice, blood plasma from F~2~ *Gif*^tm1a/tm1a^ mice exhibited alterations in multiple clinical chemistry parameters ([Fig. S1c](#figS1){ref-type="supplementary-material"}). We observed that the concentrations of iron, high-density lipoproteins, cholesterol, as well as albumin, glucose, and glycerol, were significantly lower in the blood plasma of F~2~ *Gif*^tm1a/tm1a^ mice ([Fig. S1c](#figS1){ref-type="supplementary-material"}, parts i to vi). Interestingly the level of urea, a clinical marker of muscle damage, was found to be significantly higher in the blood plasma of F~2~ *Gif*^tm1a/tm1a^ mice than in that of F~1~ *Gif*^tm1a/tm1a^ and wild-type mice (see [Fig. S2c](#figS2){ref-type="supplementary-material"}, part vii, in the supplemental material).

F~2~ *Gif*^tm1a/tm1a^ mice are hypersusceptible to *C. rodentium* and *S*. Typhimurium challenges. {#s1.3}
--------------------------------------------------------------------------------------------------

When groups of F~2~ *Gif*^tm1a/tm1a^ and wild-type mice were challenged with *C. rodentium*, 60% of the F~2~ *Gif*^tm1a/tm1a^ mice succumbed to infection by day 14 postinfection (p.i.), compared to none of the wild-type mice ([Fig. 2a](#fig2){ref-type="fig"}, part i). Although the enumeration of *C. rodentium* was statistically significantly higher in all of the organs of the challenged F~2~ *Gif*^tm1a/tm1a^ mice than in the challenged wild-type mice at day 14 p.i. ([Fig. 2a](#fig2){ref-type="fig"}, part ii), the two groups had similar colon weights and general patterns of colonic hyperplasia (see [Fig. S2](#figS2){ref-type="supplementary-material"} in the supplemental material). Significantly, however, *C. rodentium* was consistently found (*P* \< 0.001) in the livers of F~2~ *Gif*^tm1a/tm1a^ mice ([Fig. 2a](#fig2){ref-type="fig"}, part ii). Furthermore, other bacterial taxa, such as *Staphylococcus* and *Escherichia*, were also present in their livers, suggesting that polymicrobial sepsis was occurring after a *C. rodentium* challenge in these F~2~ *Gif*^tm1a/tm1a^ mice (data not shown). Importantly, bacteria were not generally detected in the livers of wild-type mice before or after a *C. rodentium* challenge.

![F~2~ *Gif*^tm1a/tm1a^ mice are susceptible to *C. rodentium* and *S*. Typhimurium pathogen challenges. (a, part i) Kaplan-Meier curve showing percent survival following infection of F~2~ *Gif*^tm1a/tm1a^ and wild-type mice with *C. rodentium* (*n* = 8). (a, part ii) Enumeration of *C. rodentium* bacteria in cecal, colon, spleen, and liver tissues of surviving F~2~ *Gif*^tm1a/tm1a^ and wild-type mice at day 14 p.i. (b, part i) Kaplan-Meier curve showing percent survival following infection of F~2~ *Gif*^tm1a/tm1a^ and wild-type mice with *S*. Typhimurium (*n* = 8). (b, part ii) Enumeration of *S*. Typhimurium bacteria in the spleens and livers of F~2~ *Gif*^tm1a/tm1a^ and wild-type mice at day 14 p.i. Gray circles represent wild-type mice. Black triangles represent F~2~ *Gif*^tm1a/tm1a^ mice. Black bars represent geometric mean values. \*\*\*, *P* \< 0.001; \*\*, *P* \< 0.01; \*, *P* \< 0.05 (ANOVA with Dunn's multiple-comparison *post hoc* test).](mbo0031628630002){#fig2}

Similar groups of wild-type and F~2~ *Gif*^tm1a/tm1a^ mice were also challenged with moderately attenuated *S*. Typhimurium M525. F~2~ *Gif*^tm1a/tm1a^ mice showed signs of salmonellosis by day 4 p.i., with all mice having to be sacrificed between days 6 and 14 p.i. ([Fig. 2b](#fig2){ref-type="fig"}, part i). In contrast, wild-type mice exhibited little sign of disease and survived the challenge. Interestingly, the *S*. Typhimurium burdens in the spleens and livers of F~2~ *Gif*^tm1a/tm1a^ and wild-type mice were comparable at day 14 p.i. ([Fig. 2b](#fig2){ref-type="fig"}, part ii). Thus, overwhelming *S*. Typhimurium burdens were unlikely to be responsible for the disease in F~2~ *Gif*^tm1a/tm1a^ mice.

Histopathological signatures are observed in F~2~ *Gif*^tm1a/tm1a^ mice before and after a pathogen challenge. {#s1.4}
--------------------------------------------------------------------------------------------------------------

A detailed histopathological analysis of tissues from naive and pathogen challenged F~2~ *Gif*^tm1a/tm1a^ and wild-type mice was performed. The general colonic and splenic morphology of naive F~2~ *Gif*^tm1a/tm1a^ mice was predominantly indistinguishable from that of wild-type mice (see [Fig. S3a](#figS3){ref-type="supplementary-material"} and [b](#figS3){ref-type="supplementary-material"} in the supplemental material). In contrast, F~2~ *Gif*^tm1a/tm1a^ mouse livers had hepatocytes with enlarged nuclei and abnormal mitotic figures ([Fig. 3a](#fig3){ref-type="fig"}, part ii), indicating liver cell karyomegaly and mitotic impairment ([@B18]).

![Representative hematoxylin- and eosin-stained sections from naive and infected F~2~ *Gif*^tm1a/tm1a^ and wild-type mice. (a) Liver sections from naive wild-type (i) and F~2~ *Gif*^tm1a/tm1a^ (ii) mice. A single asterisk indicates an abnormal mitotic figure, and double asterisks indicate enlarged cellular nuclei in an F~2~ *Gif*^tm1a/tm1a^ mouse (×400 magnification). (b) Colon sections obtained on day 14 after a *C. rodentium* challenge of wild-type (i) and F~2~ *Gif*^tm1a/tm1a^ (ii) mice. The asterisk indicates a crypt abscess in an F~2~ *Gif*^tm1a/tm1a^ mouse (×100 magnification). (c) Liver sections obtained on day 8 after an *S*. Typhimurium challenge of wild-type (i) and F~2~ *Gif*^tm1a/tm1a^ (ii) mice. Both images show inflammatory cellular infiltration and granuloma formation. Asterisks indicate the large necrotic regions seen in F~2~ *Gif*^tm1a/tm1a^ mice (× 200 magnification).](mbo0031628630003){#fig3}

Although moderate inflammation and colonic pathology were present in wild-type mice at day 14 after a *C. rodentium* challenge ([Fig. 3b](#fig3){ref-type="fig"}, part i), F~2~ *Gif*^tm1a/tm1a^ mice developed a more severe epithelial inflammatory cell infiltration, accompanied by crypt abscesses containing neutrophils and intraepithelial lymphocytes in the mucosa and increased inflammation in the submucosa ([Fig. 3b](#fig3){ref-type="fig"}, part ii, for a higher magnification, and [Fig. S3c](#figS3){ref-type="supplementary-material"}, part i, in the supplemental material). Moreover, while the livers of wild-type mice challenged with *C. rodentium* showed no obviously enhanced inflammatory cell infiltrate, challenged F~2~ *Gif*^tm1a/tm1a^ mice exhibited rich inflammatory clusters particularly around the hepatic portal triad, with a thrombus occasionally present within the hepatic portal vein (see [Fig. S3c](#figS3){ref-type="supplementary-material"}, part ii).

The liver histology of F~2~ *Gif*^tm1a/tm1a^ mice challenged with *S*. Typhimurium exhibited evidence of significantly more damage than that of wild-type mice ([Fig. 3c](#fig3){ref-type="fig"}). Both groups of infected mice harbored clusters of macrophages forming granulomas; however, there were sizable areas of necrosis and regions of foamy fatty acid hepatocytes (fat vacuoles indicating metabolic stress) in the *S*. Typhimurium challenged F~2~ *Gif*^tm1a/tm1a^ mice ([Fig. 3c](#fig3){ref-type="fig"}, part ii). The spleens of wild-type *S*. Typhimurium infected mice displayed a normal distribution of red and white pulp, but similarly challenged F~2~ *Gif*^tm1a/tm1a^ mice exhibited increased extramedullary hematopoiesis with scattered large areas of necrosis with foci of macrophages in the red pulp compacting the white pulp (see [Fig. S3d](#figS3){ref-type="supplementary-material"} in the supplemental material).

Immune profiling of naive and *S*. Typhimurium infected F~2~ *Gif*^tm1a/tm1a^ mice. {#s1.5}
-----------------------------------------------------------------------------------

We performed immune profiling before and after a challenge to identify immunological signatures associated with F~2~ *Gif*^tm1a/tm1a^ mouse susceptibility to *S*. Typhimurium ([@B19]). While we found that the percentages of peripheral blood phagocytes and natural killer cells were broadly comparable ([http://www.mousephenotype.org/data/genes/MGI:1202394](http://www.mousephenotype.org/data/genes/mgi:1202394)), we did observe slight differences in the percentages of peripheral blood CD4^+^ and CD8^+^ T cells and CD4^+^ CD25^+^ regulatory T cells ([Fig. 4a](#fig4){ref-type="fig"}, part ii, and [Fig. S4a](#figS4){ref-type="supplementary-material"} in the supplemental material) in F~2~ *Gif*^tm1a/tm1a^ mice and equivalent populations found in wild-type mice. However, when spleen leukocyte populations were analyzed at day 9 after *S*. Typhimurium infection, F~2~ *Gif*^tm1a/tm1a^ mouse T cell populations ([Fig. 4b](#fig4){ref-type="fig"}), as well as all of the other lymphocyte populations analyzed (see [Fig. S4b](#figS4){ref-type="supplementary-material"}), were comparable to those of similarly infected wild-type mice. Similarly, blood serum cytokine and chemokine analysis revealed no obvious differences between the concentrations of 25 different cytokines found in naive or infected F~2~ *Gif*^tm1a/tm1a^ mice and those in wild-type mice (see [Text S1](#textS1){ref-type="supplementary-material"}  in the supplemental material for further details).

![Immune cell profiling of naive and *S*. Typhimurium-challenged F~2~ *Gif*^tm1a/tm1a^ and wild-type mice. (a) Analysis of peripheral blood leukocytes from 16-week-old naive mice showing percentages of CD3^+^ (i) and CD4^+^ (ii) T cells. (b) Analysis of spleen cells from *S*. Typhimurium-infected mice on day 14 p.i. for total CD3^+^ (i) and total CD4^+^ (ii) T cells. Samples were analyzed on a BD LSR Fortessa or BD LSR II apparatus. Interpretation of the results was performed with FlowJo v9. Black bars represent geometric mean values. \*, *P* \< 0.05 (one-way ANOVA followed by Dunn's multiple-comparison *post hoc* test).](mbo0031628630004){#fig4}

As macrophages are critical for the control of *Salmonella* replication and the homeostasis of granulomas *in vivo* ([@B20], [@B21]), we isolated macrophages from the peritoneal cavities of naive F~2~ *Gif*^tm1a/tm1a^ and wild-type mice to evaluate their susceptibility to *S*. Typhimurium. We found that the ability of F~2~ *Gif*^tm1a/tm1a^ macrophages to kill *S*. Typhimurium was not impaired and was comparable to that of wild-type macrophages. Interestingly, we found that F~2~ *Gif*^tm1a/tm1a^ macrophages expressed higher levels of arginase 1 (see [Fig. S4c](#figS4){ref-type="supplementary-material"} in the supplemental material), a marker of alternatively activated M2 macrophages ([@B6], [@B22]).

Transcriptional profiling indicates potential cellular, metabolic, and anaplerosis pathway abnormalities in F~2~ *Gif*^tm1a/tm1a^ mice. {#s1.6}
---------------------------------------------------------------------------------------------------------------------------------------

To identify changes in gene expression that could have an impact on the phenotype of F~2~ *Gif*^tm1a/tm1a^ mice, microarray analysis was performed with mRNA prepared from the livers and colons of F~2~ *Gif*^tm1a/tm1a^ and wild-type mice with or without a pathogen challenge. Genes differentially expressed (*P* \< 0.05 with a 0.8-log-fold difference between F~2~ *Gif*^tm1a/tm1a^ and wild-type mice) under each condition were further analyzed by Ingenuity Pathway Analysis (IPA; Qiagen, Redwood City, CA), enabling the clustering of dysregulated mRNAs to specific biological and canonical pathways. Further, IPA upstream regulator analysis was used to predict potential upstream transcriptional regulators likely controlling these biological function and canonical pathways in the transcriptional data of the F~2~ *Gif*^tm1a/tm1a^ mice.

Generally, differentially expressed genes in the colons of naive F~2~ *Gif*^tm1a/tm1a^ mice were related to lipid metabolism, cell-to-cell signaling, molecular transport, small molecule biochemistry, and cell death and survival processes (see [Dataset S1b](#dataS1){ref-type="supplementary-material"} in the supplemental material). Upstream regulator analysis predicted that genes associated with glycolysis regulation (*Por*, *Clock*, *Cry1*, and *Cry2*) ([@B23], [@B24]) (see [Dataset S1a](#dataS1){ref-type="supplementary-material"}) might be controlling the functional gene profile in the colons of naive F~2~ *Gif*^tm1a/tm1a^ mice. Functional gene categories in the livers of naive F~2~ *Gif*^tm1a/tm1a^ mice were largely associated with lipid, vitamin, mineral, and nucleic acid metabolism, as well as cellular molecular transport (see [Dataset S1c](#dataS1){ref-type="supplementary-material"}), with upstream regulator analysis predicting glycolysis and fatty acid synthesis associated genes (*Gpd1*, *Slc25a13*, *RorC*, *RorA*, and *Acox1*; see [Dataset S1a](#dataS1){ref-type="supplementary-material"}) as potential regulators of disrupted cellular and biological functions in the livers of naive F~2~ *Gif*^tm1a/tm1a^ mice. In particular, *Acox1* (encodes acyl coenzyme A \[acyl-CoA\] oxidase 1, palmitoyl), a peroxisome beta-oxidation fatty acid pathway regulator ([@B25], [@B26]), was predicted by IPA to be the most statically activated of the upstream transcriptional regulators (see [Dataset S1a](#dataS1){ref-type="supplementary-material"}).

Of the differently expressed genes identified in colonic mRNA of F~2~ *Gif*^tm1a/tm1a^ mice challenged with *C. rodentium*, 60 were functionally associated with cell death and survival, with IPA predicting functional pathways associated with organismal injury and renal failure to be the most activated of these categories (see [Dataset S1d](#dataS1){ref-type="supplementary-material"} in the supplemental material). Upstream transcriptional regulator analysis highlighted *Ptger4*, a prostaglandin regulator of mucosal integrity and suppressor of innate immunity ([@B27]), as comparatively activated (see [Dataset S1a](#dataS1){ref-type="supplementary-material"}), with *Cfs2*, a modulator of epithelial cell homeostasis, as well as classical M1 macrophage activation ([@B28], [@B29]), as likely inhibiting canonical pathways in the colons of *C. rodentium*-infected F~2~ *Gif*^tm1a/tm1a^ mice (see [Dataset S1a](#dataS1){ref-type="supplementary-material"}). The top five functional gene categories in hepatic mRNA of *C. rodentium*-infected F~2~ *Gif*^tm1a/tm1a^ mice were predicted to be related to cellular function and maintenance, movement, development, growth and proliferation, and signaling, with our analysis showing many of these associated genes relatively downregulated (see [Dataset S1e](#dataS1){ref-type="supplementary-material"}). A key transcriptional regulator was predicted to be *Acox1* (see [Dataset S1a](#dataS1){ref-type="supplementary-material"}).

Finally, IPA of the hepatic mRNA data of differentially expressed genes found in *S*. Typhimurium infected F~2~ *Gif*^tm1a/tm1a^ mice was performed (see [Dataset S1a](#dataS1){ref-type="supplementary-material"} and [f](#dataS1){ref-type="supplementary-material"} in the supplemental material). Consistent with the other IPA analyses (see [Dataset S1a](#dataS1){ref-type="supplementary-material"}), *Acox1* was predicted to be a key regulatory element. Functional and canonical pathway analysis identified differentially expressed genes as associated with lipid, drug, and carbohydrate metabolism; small-molecule biochemistry; and cellular development. IPA indicated that functional pathways associated with fatty acid metabolism were overactivated (*P* = 4.39e^−06^; see [Dataset S1e](#dataS1){ref-type="supplementary-material"}).

Blood metabolic profiling identifies F~2~ *Gif*^tm1a/tm1a^ mice as having abnormal glycolytic pathways and cellular energy homeostasis pathways. {#s1.7}
------------------------------------------------------------------------------------------------------------------------------------------------

To identify metabolites that might be influenced downstream of the changes in transcriptional patterns observed in the tissues of F~2~ *Gif*^tm1a/tm1a^ mice, metabotyping was performed by nuclear magnetic resonance (NMR) spectroscopy of blood serum taken from F~2~ *Gif*^tm1a/tm1a^ and wild-type mice before and after an *S*. Typhimurium challenge. By performing principal component analysis (PCA), a multivariate data analysis method, we could distinguish the blood serum metabolic profiles of naive ([Fig. 5a](#fig5){ref-type="fig"}), as well as *S*. Typhimurium infected ([Fig. 5b](#fig5){ref-type="fig"}) F~2~ *Gif*^tm1a/tm1a^ and wild-type mice.

![Metabotyping of blood serum from F~2~ *Gif*^tm1a/tm1a^ and wild-type mice reveals metabolic abnormalities. (a) PCA score plot separating naive F~2~ *Gif*^tm1a/tm1a^ mice (green circles) from naive wild-type mice (blue circles) with 92% of the variables explained (*R*^2^~cum~) by using the first four components with 72% predictability minus Q2. (b) Multivariate data analysis results comparing the blood serum of uninfected F~2~ *Gif*^tm1a/tm1a^ (ui_gif; red circles) and wild-type (ui_wt; yellow circles) mice and that of *S*. Typhimurium-infected F~2~ *Gif*^tm1a/tm1a^ (si_gif; green circles) and wild-type (si_wt; blue circles) mice. Principal component 1 discriminates on the basis of the presence or absence of infection, while principal component 2 separates different mouse genotypes, regardless of infection status. Ninety percent of the variables (*R*^2^~cum~) were explained by using the first five components with 73% predictability.](mbo0031628630005){#fig5}

As expected, uninfected wild-type mice demonstrated blood metabolic patterns of normal cellular homeostasis, harboring higher levels of fatty acids and glucose ([Table 1](#tab1){ref-type="table"}). In contrast, naive F~2~ *Gif*^tm1a/tm1a^ mice harbored a metabolic profile with similarities to the Warburg effect ([@B30]). This profile included higher levels of lactate and lower quantities of glucose, indicating that lactic acid fermentation was occurring to generate energy for cellular homeostasis. We also identified biomarkers of alternative cellular energy sourcing such a decrease amount of fatty acids and an increased quantity of citrate-aspartate, metabolites commonly associated with increased glycolysis and acetyl-CoA production ([Table 1](#tab1){ref-type="table"}; see [Fig. S5](#figS5){ref-type="supplementary-material"}, in the supplemental material). Furthermore, we observed a high level of methylmalonate, a known plasma marker of Cbl deficiency, in the blood of naive F~2~ *Gif*^tm1a/tm1a^ mice, suggesting that Cbl deficiency could be disrupting the trichloroacetic acid (TCA) cycle ([@B14], [@B15]).

###### 

Summary of the relative metabolic differences in the blood serum of naive and *S*. Typhimurium-infected F~2~ *Gif*^tm1a/tm1a^ and wild-type mice[^a^](#ngtab1.1){ref-type="table-fn"}

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Metabolite(s)              Chemical shift(s) (ppm)          Fold change(s)[^b^](#ngtab1.2){ref-type="table-fn"}   
  -------------------------- -------------------------------- ----------------------------------------------------- ------------------------------------------------
  Fatty acids                Several                          ↓−1.2                                                 ---, ↑1.4[^c^](#ngtab1.3){ref-type="table-fn"}

  Putrescine-cadaverine      1.75, 3.04; 1.48, 3.80           ---                                                   ↑

  Glucose                    3.24, 3.46, 3.52, 3.73; 3.83,\   ↓−1.2                                                 ↓−1.3
                             3.88, 5.22                                                                             

  Fucose                     1.22, 1.25, 3.44, 3.60, 3.80,\   ---                                                   ↓−1.5
                             5.25                                                                                   

  Acetate                    1.93                             ↑                                                     ---

  Alanine                    1.49, 1.51, 3.81                 ↑                                                     ---

  Taurine-betaine            3.27, 3.44; 3.25, 3.90           ↑                                                     ↓−1.3, −2[^c^](#ngtab1.3){ref-type="table-fn"}

  Citrate-aspartate          2.55, 2.67; 2.64, 2.70           ↑1.2                                                  ---

  Formate                    8.47                             ↑                                                     ---

  Glutamate-glutamine        (2.04, 2.12), (2.34, 2.39),\     ↓                                                     ---
                             3.74; (2.00, 24.00, 2.48),\                                                            
                             3.78                                                                                   

  Isoleucine                 0.98, 1.01, 3.66                 ↓                                                     ---

  Leucine                    0.96, 1.72, 3.75                 ↓                                                     ↓−1.6

  Methylmalonate             1.22, 3.18                       ↑1.3                                                  ↑1.2

  Phenylacetylglycine        3.68, 3.76, 7.40                 ↑                                                     ↑

  Valine                     1.01, 1.06, 2.29, 3.61           ---                                                   ↑

  Adipate                    1.56, 2.17                       ---                                                   ---, ↑1.6[^c^](#ngtab1.3){ref-type="table-fn"}

  3-Hydroxybutyrate          1.21, (2.32, 2.42), 4.16         ---                                                   ↓

  Butyrate                   0.89, 1.56, 2.15                 ---                                                   ↓

  Lactate                    1.34, 4.13                       ↑1.2                                                  ---

  Pyruvate-succinate         2.39, 2.41                       ↑                                                     ---

  Choline-phosphocholine-\   3.20, 3.21, 3.22\                ---\                                                  ↑
  glycerophosphocholine                                                                                             

  Malate                     (2.36, 2.42), (2.66, 2.70),\     ---                                                   ↑
                             4.30                                                                                   
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------

Fold change, \>1.2; *P* \< 0.05.

Shown are fold (\>1.2) and significant (*P* \< 0.05) changes in metabolite levels in F~2~ *Gif*^tm1a/tm1a^ and wild-type mice.

Shown are fold (\>1.2) and significant (*P* \< 0.05) changes in metabolite levels in naive versus *S*. Typhimurium-infected F~2~ *Gif*^tm1a/tm1a^ mice. Symbols: ---, no significant fold change (\>1.2); ↑  or ↓, relative increase or decrease in metabolites from PCA loading plots. These levels were estimated from relative intensities (median) of ^1^H NMR spectra following spectral normalization.

Next, we metabotyped blood serum from wild-type and F~2~ *Gif*^tm1a/tm1a^ mice at day 9 after an *S*. Typhimurium challenge ([Fig. 5b](#fig5){ref-type="fig"}). *S*. Typhimurium is known to cover its metabolic needs during infection by upregulating host cell glycolysis and associated fatty acid beta-oxidation pathways ([@B22], [@B31], [@B32]), with the blood of infected wild-type mice harboring relatively higher levels of metabolites indicative of beta oxidation activity such as 3-hydroxybutyrate and butyrate and adipate ([Table 1](#tab1){ref-type="table"}). In contrast, challenged F~2~ *Gif*^tm1a/tm1a^ mice exhibited biomarkers associated with severe changes in cellular energy homeostasis and glycolytic processes, as well as metabolic starvation ([@B30], [@B33]). We identified lower levels of blood sugars (glucose and fucose), with taurine ([Table 1](#tab1){ref-type="table"}), and leucine, metabolites thought to regulate maurine skeletal function as well as glucose and lipid homeostasis ([@B12], [@B34]) reduced in the blood of infected F~2~ *Gif*^tm1a/tm1a^ mice. We also observed biomarkers of increased acetyl-CoA and fatty acid synthesis (fatty acids, valine, and phenylacetylglycine), and increased oxidative stress (adipate, taurine-betaine, chlorine, and malate) ([@B30]). Furthermore, and comparative to their uninfected F~2~ *Gif*^tm1a/tm1a^ counterparts, the plasma Cbl marker methylmalonate was observed at high levels in the blood metabolite profile of infected F~2~ *Gif*^tm1a/tm1a^ mice ([Table 1](#tab1){ref-type="table"}).

Cbl supplementation reverses the *S*. Typhimurium susceptibility of F~2~ *Gif*^tm1a/tm1a^ mice. {#s1.8}
-----------------------------------------------------------------------------------------------

To evaluate if F~2~ *Gif*^tm1a/tm1a^ Cbl deficiency was directly impacting their hypersusceptibility to *C. rodentium* and *S*. Typhimurium infection, we supplemented F~2~ *Gif*^tm1a/tm1a^ mice with Cbl in a series of subcutaneous injections prior to a challenge and compared their susceptibility to an *S*. Typhimurium M525 challenge with that of untreated F~2~ *Gif*^tm1a/tm1a^ mice. As expected, untreated F~2~ *Gif*^tm1a/tm1a^ mice showed signs of salmonellosis by day 4 p.i. and had to be sacrificed by day 7 p.i. ([Fig. 6](#fig6){ref-type="fig"}). In contrast, equivalent Cbl-treated F~2~ *Gif*^tm1a/tm1a^ mice exhibited limited signs of salmonellosis, survived the challenge, and were indistinguishable from their wild-type counterparts. Thus, Cbl deficiency in these F~2~ *Gif*^tm1a/tm1a^ mice is likely directly influencing their susceptibility to *S*. Typhimurium infection.

![Cbl supplementation of F~2~ *Gif*^tm1a/tm1a^ mice alters their susceptibility to an *S*. Typhimurium challenge. Shown is a Kaplan-Meier curve of percent survival of F~2~ *Gif*^tm1a/tm1a^ mice left untreated or treated with cyanocobalamin and then infected with *S*. Typhimurium (*n* = 8).](mbo0031628630006){#fig6}

DISCUSSION {#h2}
==========

By exploiting a novel *Gif* mutant mouse line, we have demonstrated a critical role for Cbl in controlling susceptibility to infection by two different bacterial pathogens, *C. rodentium* and *S*. Typhimurium. We link this severe phenotype to likely disruptions in glycolysis, fatty acid synthesis, and energy homeostasis processes in Cbl-defective mice ([@B12], [@B14], [@B30], [@B31], [@B33]), with infection susceptibility further being influenced by the genotype of mothers, a phenomenon linked to their ability to transfer Cbl to their offspring ([@B35]).

The results obtained with Gif deficient mice mimic aspects of the clinical phenotypes associated with Cbl deficiency in humans and other mammals. For example, children born to Cbl depleted mothers exhibit stunted growth ([@B10]), similar to that observed in F~2~ *Gif*^tm1a/tm1a^ mice and infant rats and mice when Cbl was removed from their diet ([@B16], [@B35], [@B36]). Further, we demonstrate how Cbl deficiency can likely disrupt mammalian cellular homeostasis processes. F~2~ *Gif*^tm1a/tm1a^ mice exhibited blood and histopathological signatures associated with DNA abnormalities such as megaloblastic anemia, abnormal mitotic figures, and cellular oxidative damage, phenotypes commonly associated with Cbl deficiency in humans and infant mice ([@B8], [@B9], [@B11], [@B13]). By metabolomic and transcriptional profiling, we also found evidence that succinyl-CoA, a Cbl by-product and an essential TCA cycle regulator, was inhibited in F~2~ *Gif*^tm1a/tm1a^ mice, likely leading to increased glycolysis and fatty acid synthesis and other metabolic activities commonly associated with the Warburg effect ([@B12][@B13][@B15], [@B30]).

We were unable to detect a clear immunological signature associated with Cbl deficiency in F~2~ *Gif*^tm1a/tm1a^ mice, even though others have reported that Cbl deficiency affects cytokine and T cell ratios in a uninfected host ([@B37], [@B38]). Clearly, we did not exhaustively screen for immune deficiencies, and further studies in this area are still warranted. However, the macrophage killing activity that is critical for controlling salmonellosis *in vivo* was not obviously impaired, and immune cell populations and cytokine levels critical for *Salmonella* control appeared to be broadly similar ([@B19]). Interestingly however, and perhaps consistent with the Warburg effect ([@B6]), we did identify signatures for alternatively activated M2 macrophages, such as increased expression of arginase 1 by F~2~ *Gif*^tm1a/tm1a^ mouse macrophages. We therefore concluded, like the authors of a previously published study ([@B22]), that this metabolic activation state has little impact on the control of *Salmonella* replication because these cells were still able to kill salmonellae *in vitro*.

After *C. rodentium* infection, F~2~ *Gif*^tm1a/tm1a^ mice exhibited polymicrobial sepsis, with an overgrowth of *C. rodentium*. Histopathological examination revealed greater recruitment of inflammatory cells to the colon and liver than similarly infected wild-type mice, with transcriptional profiling suggesting that cellular homeostasis processes are likely disrupted in F~2~ *Gif*^tm1a/tm1a^ mice after *C. rodentium* infection. F~2~ *Gif*^tm1a/tm1a^ mice infected with *S*. Typhimurium exhibited greater signs of lethargy and morbidity, with severe histopathological damage. As *S*. Typhimurium utilizes the same fatty acid beta-oxidation and glycolysis pathways that are already dysregulated in F~2~ *Gif*^tm1a/tm1a^ mice ([@B22], [@B31], [@B32]), we hypothesize that F~2~ *Gif*^tm1a/tm1a^ mice are succumbing to *S*. Typhimurium infection from metabolic starvation, with their metabolomic and transcriptional profile strongly resembling this scenario ([@B33]).

This study has further highlighted some of the complex clinical and metabolomic abnormalities associated with Cbl deficiency, demonstrating the importance of Cbl in the mammalian diet. By performing studies on *Gif*^tm1a/tm1a^ or other mice with genetic defects associated with nutrient absorption, we can not only gain a better biological understanding of the interplay between nutritional regulation and the immune system but also further understand the pathogenesis associated with specific nutritional dysregulation.

MATERIALS AND METHODS {#h3}
=====================

Animals. {#s3.1}
--------

The *Gif*^tm1a(KOMP)Wtsi^ mouse line was generated on a C57BL/6N genetic background as part of the International Mouse Phenotyping Consortium (<http://www.mousephenotyping.org>). See [Text S1](#textS1){ref-type="supplementary-material"}  in the supplemental material for the gene targeting methods used to produce this mouse line. Animals were housed under specific-pathogen-free conditions in HEPA-filtered cages with sterile bedding and given a sterilized standard diet and water *ad libitum*. All experiments were performed in accordance with United Kingdom Animal (Scientific Procedures) Act 1986.

Hematology and blood chemistry analysis. {#s3.2}
----------------------------------------

Blood was collected under terminal anesthesia into either EDTA-coated tubes or heparinized tubes for plasma or serum preparation. Clinical chemistry analysis of plasma was performed with the Olympus AU400 analyzer (Beckman Coulter Ltd., High Wycombe, United Kingdom). Concentrations of Cbl in plasma were measured with the ADVIA Centaur immunoassay analyzer (Siemens).

Cbl treatment. {#s3.3}
--------------

Mice were treated subcutaneously with cyanocobalamin (Sigma Aldrich) at 1 mg/ml every 2 weeks for 6 weeks. Mice were left for 1 month before an *S*. Typhimurium infection challenge.

Cytokine analysis. {#s3.4}
------------------

Cytokine analysis was performed with the FlexMap 3D (Luminex) machine with a Milliplex Map Mouse Th17 Magnestic Bead Panel 96-well assay kit (Millipore). For method details, as well as a list of the cytokines analyzed, see [Text S1](#textS1){ref-type="supplementary-material"} in the supplemental material.

Flow cytometry analysis. {#s3.5}
------------------------

Analysis of peripheral blood leukocytes was performed with heparinized blood collected from 16-week-old mice. Peripheral blood leukocytes, mesenteric lymph nodes, and spleens were prepared and stained for flow cytometry analysis as described in [Text S1](#textS1){ref-type="supplementary-material"} in the supplemental material. All samples were analyzed on an LSR II or LSR Fortessa apparatus (BD Biosciences). Data were analyzed with FlowJo v9 software (TreeStar).

Histological analysis. {#s3.6}
----------------------

For histological examination, 5-µm sections of paraffin-embedded tissues were stained with hematoxylin and eosin (Sigma-Aldrich). Sections were examined and scored by a pathologist under blinded conditions. For immunohistochemistry analysis, sections were cut and fixed as described in [Text S1](#textS1){ref-type="supplementary-material"} in the supplemental material. Sections were visualized by confocal microscopy (Leica).

NMR analysis. {#s3.7}
-------------

Blood serum was collected from age- and sex-matched mice (five per group), snap-frozen immediately, and stored at −80°C until analysis. Samples were analyzed with a Bruker ADVANCE III NMR spectrometer to identify metabolic differences between F~2~ *Gif*^tm1a/tm1a^ and wild-type mice. For further details, see [Text S1](#textS1){ref-type="supplementary-material"} in the supplemental material.

Microarray analysis. {#s3.8}
--------------------

mRNA for microarray analysis was prepared as described in [Text S1](#textS1){ref-type="supplementary-material"} in the supplemental material. Analysis was performed with the Illumina MouseWG-6 v2.0 Expression BeadChip kit. The data were analyzed with BeadStudio Software (Illumina) to identify genes differently regulated in F~2~ *Gif*^tm1a/tm1a^ and wild-type mice. Further pathway analysis was performed by IPA (Qiagen, Redwood City, CA) of all of the genes differently expressed in F~2~ *Gif*^tm1a/tm1a^ and wild-type mice (*P* \< 0.05; log-fold change, 0.8). For further details of the IPA analysis performed, see [Text S1](#textS1){ref-type="supplementary-material"} in the supplemental material.

RNA isolation and RT-qPCR of peritoneal macrophages. {#s3.9}
----------------------------------------------------

Resident peritoneal macrophages were isolated from naive mice by peritoneal lavage. RNA was isolated with the RNeasy minikit (Qiagen) and reverse transcribed with the QuantiTect reverse transcription (RT) kit (Qiagen). RT-quantitative PCR (RT-qPCR) experiments were performed as described in [Text S1](#textS1){ref-type="supplementary-material"} in the supplemental material.

Mouse infection challenges. {#s3.10}
---------------------------

Background matched wild-type and *gif*^tm1a(KOMP)Wtsi^ mice 6 to 10 weeks of age were maintained in accordance with United Kingdom Home Office regulations under project license PPL80/2099 and 80/2596 (2596 replaced 2099 upon expiry). The Wellcome Trust Sanger Institute Ethical Review Committee has also reviewed this license. For *C. rodentium* challenges, mice were infected orally with 0.2 ml of *C. rodentium* ICC180. For *S*. Typhimurium challenges, mice were infected intravenously with a sublethal dose of *S*. Typhimurium M525. All mice were monitored daily for defined humane endpoints in accordance with United Kingdom Home Office license guidelines.

Measurement of pathogen burdens in organs. {#s3.11}
------------------------------------------

Organs were aseptically removed and homogenized mechanically. Viable counts were determined by serially diluting the organ homogenates onto LB agar plates for CFU counting.

Peritoneal macrophage gentamicin protection assay. {#s3.12}
--------------------------------------------------

Peritoneal macrophages were infected with *S*. Typhimurium M525 at a multiplicity of infection (MOI) of 20 for 1 h and then treated with gentamicin for another hour. Cells were then washed and incubated in antibiotic-free Opti-MEM (Thermo Fisher) for a further 5 h. For quantitative analysis, cells were lysed in 1% Triton X-100, serially diluted, and plated onto LB plates for CFU counting.

Statistical analysis. {#s3.13}
---------------------

Where not already stated in [Text S1](#textS1){ref-type="supplementary-material"} in the supplemental material, the Student *t* test was performed for experiments comparing two groups. For data with more than two groups, statistical analysis was performed by a nonparametric one-way analysis of variance (ANOVA) with Dunn's multiple-comparison *post hoc* test. For comparisons of groups with two or more factors, analysis was performed by two-way ANOVA with the Bonferroni multiple-comparison posttest. *P* \< 0.05 was taken as significant in all cases. All tests were performed with GraphPad Prism 5 (GraphPad Software, Inc., La Jolla, CA).

Microarray data accession numbers. {#s3.14}
----------------------------------

The microarray data associated with this paper are stored in the ArrayExpress public database (<http://www.ebi.ac.uk/arrayexpress>) under accession numbers E-MTAB-1879 and E-MTAB-1880.
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Details of the materials and methods used in this study, including descriptions of the gene targeting and mouse production, Cbl analysis and treatment, hematology and blood chemistry analyses, flow cytometry analysis of immune cell populations, NMR analysis, microarray analysis, mouse infection challenges, measurement of pathogen burdens in organs, histological analysis, cytokine analysis, resident peritoneal macrophage assays, and statistical analyses. Download
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Text S1, DOCX file, 0.2 MB
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Summary of the mRNA transcriptional regulators and specific biological and conical pathways identified as part of IPA. This analysis was performed using microarray data comparing mRNA extracted from F~2~ *Gif*^tm1a/tm1a^ mice to mRNA extracted from wild-type mice (*P* \< 0.05 with 0.8-log fold change). The mRNA was prepared from the livers and colons of F~2~ *Gif*^tm1a/tm1a^ and wild-type mice with or without a pathogen challenge. Download
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Dataset S1, XLS file, 0.4 MB
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Histological, hematologic, and plasma defects are present in F~2~ *Gif*^tm1a/tm1a^ mice. (a) Representative hematoxylin and eosin stained spleen sections from naive F~2~ *gif*^tm1a/tm1a^ and wild-type mice showing that megakaryocytes were often hyperlobulated and hypersegmented in F~2~ *Gif*^tm1a/tm1a^ mice. Part i, wild-type mice; part ii, F~2~ *Gif*^tm1a/tm1a^ mice (×400 magnification). (b and c) Hematology and plasma chemistry analyses of F~2~ (black triangles), F~1~ (gray stars) *Gif*^tm1a/tm1a^, and wild-type (gray circles) mice at 16 weeks of age. (a, part i) Total red blood cell count per microliter, (ii) MCV of red blood cells in femtoliters. (b) Concentrations of iron (millimolar) (i), high density lipoproteins (millimolar) (ii), cholesterol (millimolar) (iii), glucose (nanomolar) (iv), glycerol (nanomolar) (v), albumin (grams per liter) (vi), and urea (nanomolar) (vi) in plasma. Black bars represent geometric mean values. \*\*\*, *P* \< 0.001; \*\*, *P* \< 0.01; \*, *P* \< 0.05 (ANOVA with Dunn's multiple-comparison *post hoc* test). Download
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Figure S1, DOCX file, 0.7 MB
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\(a\) Colon mass (grams) and (b) average colonic crypt length (micrometers) of naive and *C. rodentium*-infected (day 14 p.i.) F~2~ *Gif*^tm1a/tm1a^ and wild-type mice. Gray circles represent wild-type mice, and black triangles represent F~2~ *Gif*^tm1a/tm1a^ mice. Black bars represent geometric mean values. Download
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Figure S2, DOCX file, 0.1 MB

###### 

Representative hematoxylin- and eosin-stained sections from naive and infected F~2~ *Gif*^tm1a/tm1a^ and wild-type mice. (a) Naive wild-type (i) and *Gif*^tm1a/tm1a^ (ii) mouse colon tissues (×100 magnification). (b) Naive wild-type (i) and F~2~ *Gif*^tm1a/tm1a^ (ii) mouse spleen tissues (×100 magnification). (c) F~2~ *Gif*^tm1a/tm1a^ mice 14 days after *C. rodentium* infection: i, colonic crypt abscess (\*; ×400 magnification); ii, thrombi in the hepatic portal vein (\*\*; ×200 magnification). This was not observed in the livers of wild-type mice (data not shown). (d) Spleen sections from wild-type mice (i) (×100 magnification) and F~2~ *Gif*^tm1a/tm1a^ mice (ii) on day 14 after *S*. Typhimurium infection. Asterisks indicate large necrotic areas not seen in wild-type infected mice (×200 magnification). Download

###### 

Figure S3, DOCX file, 2.4 MB

###### 

Profiling of immune cells from naive F~1~ *Gif*^tm1a/tm1a^ (gray stars), F~2~ *Gif*^tm1a/tm1a^ (black triangles), and wild-type (gray circles) mice. (a) Peripheral blood lymphocyte analysis of percentages of regulatory T cells (i) and CD8^+^ cytotoxic T cells (ii). All samples were analyzed on a BD LSR II analyzer. (b) Analysis of wild-type and *Gif*^tm1a/tm1a^ mouse splenocytes on day 14 after *S*. Typhimurium infection. Shown are the total Gr-1 (i), F4/80 (ii), and B220 (iii) cells. All samples were analyzed on a BD LSR Fortessa analyzer. Interpretation of the results was performed with FlowJo (v9). (c) Resident peritoneal macrophages were isolated from naive wild-type and F~2~ *Gif*^tm1a/tm1a^ mice, and relative expression of the arginase 1-encoding gene was compared by RT-qPCR. (d) The microbicidal abilities of wild-type and F~2~ *Gif*^tm1a/tm1a^ mouse macrophages were compared by gentamicin protection assay. Thioglycolate-elicited peritoneal macrophages were infected with *S*. Typhimurium M525 at an MOI of 20 in serum-free medium, and 5 h after gentamicin treatment, cells were lysed and plated on agar plates in different dilutions and CFU were counted. Black bars represent geometric mean values. Statistical analysis was performed by ANOVA with Dunn's multiple-comparison *post hoc* test for panels a and b and Student's *t* test for panels c and d. \*, *P* \< 0.05; \*\*, *P* \< 0.01; \*\*\*, *P* \< 0.001. Download
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High-resolution 600-MHz ^1^H NMR spectrum of blood serum from F~2~ *Gif*^tm1a/tm1a^ mice. Peaks: mobile fatty acids and lipoproteins \[1, −CH~3~/cholesterol; 2, −(CH~2~)~n~−; 36, −CH~2~CH~2~CO; 11, −CH~2~C═C; 14, −CH~2~C═O; 20, ═C-(CH~2~)--C═; 25, -N(CH~3~)~3~\]; 3, leucine and isoleucine; 4, valine; 5, 3-hydroxybutyrate; 6, methylmalonate; 7, lactate; 8, alanine; 9, cadaverine-putrescine; 10, acetate; 12, glutamine and glutamate; 13, methionine; 15, 3-hydroxybutyrate; 16, pyruvate; 17, succinate and malate; 18, glutamine; 19, citrate; 21, lysine-cadaverine; 22, creatine; 23, methylmalonate; 24, choline; 26, glucose; 27, glycine; 28, betaine-taurine; 29, serine; 30, phenylacetylglycine; 31, alpha-glucose; 32, mobile unsaturated lipids; 33, fumarate; 34, tyrosine; 35, phenylalanine; 37, allantoin. Download
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